Shawn Michael Jennings

Title: **Innovator Spotlight: Shawn Michael Jennings**

Introduction

Shawn Michael Jennings, an accomplished inventor based in Acton, MA, has made significant contributions to the field of biotechnology. With a portfolio of five patents, he demonstrates a commitment to advancing medical science through innovative research and development.

Latest Patents

Shawn's most notable patents include the groundbreaking work on Anti-LAG-3 antibodies and methods of use thereof. This patent includes antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize its function. The disclosure encompasses pharmaceutical compositions comprising these antibodies, nucleic acids encoding the antibodies, expression vectors, and host cells used for creating these antibodies. Furthermore, it outlines methods for treating subjects using these novel antibodies.

Career Highlights

Shawn Michael Jennings works at Agenus Inc., a notable company in the biotechnology sector. His role involves pioneering research that aims to develop therapeutic interventions for various diseases, utilizing his extensive knowledge and innovative thinking.

Collaborations

At Agenus Inc., Shawn collaborates with talented professionals, including his coworkers Nicholas Stuart Wilson and David Adam Savitsky. These partnerships foster a dynamic work environment that enhances creativity and drives the development of groundbreaking treatments in the biotech industry.

Conclusion

Shawn Michael Jennings exemplifies the spirit of innovation within biotechnology, with his patents advancing the understanding and treatment of diseases. His work not only highlights his individual expertise but also underscores the importance of collaboration in the quest for scientific advancement.